References

Real-time monitoring of a digestive tract marker to reduce adverse effects of moving organs at risk (OAR) in radiotherapy for thoracic and abdominal tumors

10.1016/j.ijrobp.2005.01.006 · 2005 · External reference

INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy

10.1200/jco.2002.20.5.1167 · 2002 · External reference

Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: Mature results of phase II study

10.1016/j.ijrobp.2004.03.031 · 2004 · External reference

Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus

10.1200/jco.2003.03.055 · 2003 · External reference

Unresolved reference

2005 · External reference

Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma

10.1016/j.ijrobp.2006.09.015 · 2007 · External reference

Esophageal motion during radiotherapy: Quantification and margin implications

10.1111/j.1442-2050.2009.01037.x · 2010 · External reference

Unresolved reference

1999 · External reference

Four dimensional radiotherapy: A review of current technologies and modalities

10.1007/s13246-012-0178-5 · 2012 · External reference

Determination of respiratory motion for distal esophagus cancer using four-dimensional computed tomography

10.1016/j.ijrobp.2007.05.031 · 2008 · External reference

Implications of respiratory motion as measured by four-dimensional computed tomography for radiation treatment planning of esophageal cancer

10.1016/j.ijrobp.2008.12.060 · 2009 · External reference

Comparison of patient-specific internal gross tumor volume for radiation treatment of primary esophageal cancer based separately on three-dimensional and four-dimensional computed tomography images

10.1111/dote.12089 · 2014 · External reference

Four-dimensional measurement of the displacement of internal fiducial markers during 320-multislice computed tomography scanning of thoracic esophageal cancer

10.1016/j.ijrobp.2010.03.045 · 2011 · External reference

Quantification of respiration-induced esophageal tumor motion using fiducial markers and four-dimensional computed tomography

10.1016/j.radonc.2016.01.005 · 2016 · External reference

Differences in displacement of the proximal and distal ends of mid-upper thoracic esophageal squamous cell carcinoma

10.3892/mco.2016.899 · 2016 · External reference

Determination of internal target volume for radiation treatment planning of esophageal cancer by using 4-dimensional computed tomography (4DCT)

10.1016/j.ijrobp.2014.05.015 · 2014 · External reference

Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer

2006 · External reference

Histologic tumor type is an independent prognostic parameter in esophageal cancer: Lessons from more than 1,000 consecutive resections at a single center in the Western world

10.1097/00000658-200109000-00010 · 2001 · External reference

A comparison of tumor motion characteristics between early stage and locally advanced stage lung cancers

10.1016/j.radonc.2012.04.010 · 2012 · External reference